Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial).

José MolinaClara María Rosso-FernándezEnrique Montero-MateosJosé Ramón Paño-PardoMaría SollaAna Belén Guisado-GilRocío Álvarez-MarínMaría Eugenia Pachón-IbáñezAdelina GimenoGuillermo Martín-GutiérrezJosé Antonio LepeJosé Miguel Cisnerosnull null

Published in: PloS one (2022)

EudraCt: 2021-003847-10; ClinicalTrials.gov: NCT05210439.

Keyphrases

pseudomonas aeruginosa
cystic fibrosis
clinical trial
study protocol
phase iii
biofilm formation
escherichia coli
double blind